Bioverge
Early Stage
Fusing sci-fi with fintech through a health + tech investment platform
Overview
Raised: $70,724
Rolling Commitments ($USD)
Status
Active
Reporting Date
06/10/2023
Days Remaining
58
% of Min. Goal
283%
% of Max. Goal
6%
Likelihood of Max
Avg. Daily Raise
$2,439
# of Investors
7
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2017
Industry
Financial & Insurance Products & Services
Tech Sector
Fintech
Distribution Model
B2B/B2C
Margin
High
Capital Intensity
Low
Bioverge, with a valuation of $25 million, is raising funds on Republic. The company has developed a health technology investment platform to merge sci-fi with fintech. The platform is democratizing investing in curated healthcare technology startups with its portfolio of 37 companies with a value of over $3 billion. Bioverge offers a variety of investment options, including deal-by-deal investments, Bioverge Access funds, and thematic funds. Neil Littman and Rick Gibb founded Bioverge in August 2017. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for product development, sales and marketing, new hires, and working capital.
Summary Profit and Loss Statement
FY 2022 | FY 2021 | |
---|---|---|
Revenue |
$247,786 |
$251,720 |
COGS |
$49,972 |
$26,101 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-406,203 |
$-591,903 |
Summary Balance Sheet
FY 2022 | FY 2021 | |
---|---|---|
Cash |
$324,314 |
$487,668 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$567,769 |
$751,759 |
Short-Term Debt |
$52,668 |
$178,120 |
Long-Term Debt |
$0 |
$0 |
Total Liabilities |
$52,668 |
$178,120 |
Financials as of: 05/12/2023
Create a free account today to gain access to KingsCrowd analytics.
Raise History
Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|---|
Bioverge | 08/07/2023 | Republic | $25,000,000 | $70,724 | SAFE | Active | RegCF |
Bioverge | 02/28/2022 | Netcapital | $10,014,900 | $710,266 | Equity - Common | Funded | RegCF |
Bioverge | 05/13/2021 | Netcapital | $10,014,900 | $0 | Equity - Common | Funded | Test the Waters / RegCF |
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.